PD-360324

N/A

Report date: 2023/05/09 20:00:38

Base Information

Drug NamePD-360324
Drug Alias NamePD-0360324PD-360324
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionMacrophage colony stimulating factor 2 inhibitorsMacrophage Colony Stimulating Factor 1 inhibitors
TargetsMacrophage Colony Stimulating Factor 1Macrophage colony stimulating factor 2
Therapy Area/IndicationsLupus Erythematosus, CutaneousSarcoidosis, PulmonaryNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[9] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, CutaneousSarcoidosis, PulmonaryNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A